Randomized Trial of Pharmacist Prescribing in Perioperative Medication Management

A 2020 randomized controlled trial from a Brisbane tertiary hospital evaluated a pharmacist-led prescribing model against usual care for 400 elective surgery patients. The dataset contains results comparing the frequency and clinical significance of medication omissions and prescribing errors between the two groups. Secondary outcomes include the appropriateness of venous thromboembolism (VTE) prophylaxis prescribing.

Use Cases

• Compare the frequency of medication omissions between pharmacist-generated and resident medical officer-generated charts for 400 patients.
• Analyze the clinical significance of prescribing errors involving drug, dose, or frequency selection across trial arms.
• Evaluate the appropriateness of VTE prophylaxis prescribing on patient admission to the ward.
• Model the relationship between prescribing model (intervention vs. control) and the occurrence of unclear or incorrect prescription components.

Strengths

• Data originates from a randomized controlled trial design with 400 participants, providing a structured comparison.
• Primary outcomes are quantified with specific statistical results, such as 1.2% omission rate in the intervention group versus 31.5% in control.

Limitations

• Dataset scope is limited to a single center in Brisbane, Australia, which may affect generalizability.
• The raw description does not specify the available data columns, sample data, or row count, limiting detailed assessment of its structure.

Provenance

Source

Dryad

Collection Method

Single-center, randomized controlled trial conducted in an elective surgery pre-admission clinic.

Freshness

2020-06-24

Geography

Brisbane, Australia